Therapeutic class insights

Discover crucial insights into therapeutic areas driving significant financial and clinical impacts.

Strategic insights for effective decision making

Staying informed about leading spend drivers, emerging pipeline therapies, recent drug approvals, utilization trends and critical market and policy developments is essential for effective formulary decisions and budget planning. With accelerating innovation in cell and gene therapies, targeted biologics and pediatric treatments, proactive planning is crucial. Vizient empowers pharmacy leaders and supply chain decision-makers with strategic insights to anticipate spending trends, mitigate risks and align clinical and financial objectives.

Explore specific therapeutic classes

Dive deeper into detailed insights and analysis for each therapeutic class.

Autoimmune and chronic inflammatory diseases

Autoimmune and chronic inflammatory diseases

Keeping you at the forefront of price projections and market developments in healthcare supply

The winter 2025 Spend Management Outlook represents our best estimate of healthcare supply chain market prices between July 1, 2025 and June 30, 2026.

Access the report

SMO winter 2025